Concepedia

Mie Linder Hübbe

ML

Statistics

Publications

5

Citations

168

H-Index

5

Active since

2020

Affiliations

University of Copenhagen(Current)

Herlev Hospital

University of Southern Denmark

Copenhagen University Hospital

Mie Linder Hübbe is an author at University of Copenhagen specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2020–2022

5

Publications

5

Arginase 1–Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti–PD-1 Checkpoint Blockade

Mia Aaboe Jørgensen, Stefano Ugel, Mie Linder Hübbe et al. · Cancer Immunology Research · 2021 · 61 citations · Full text

, , +17

TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer

Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina et al. · Journal for ImmunoTherapy of Cancer · 2022 · 45 citations · Full text

, , +17

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

Stine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström et al. · OncoImmunology · 2020 · 32 citations · Full text

, , +17

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco et al. · Journal for ImmunoTherapy of Cancer · 2022 · 17 citations · Full text

, , +17

Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens

Ditte Elisabeth Jæhger, Mie Linder Hübbe, Martin Kisha Kræmer et al. · Scientific Reports · 2021 · 13 citations · Full text

, , +17

1–5 of 5